Categories: All postsCannabis

Origin House is undervalued, says Beacon Securities

Cannabis sector analyst Doug Cooper of Beacon Securities says assessments of Origin House’s (Origin House Stock Quote, Chart CSE:OH) value seem to have overlooked one piece of the company’s puzzle that may prove more significant as time goes by.

In a deal announced last September and still to be closed, OH is paying $25 million for 180 Smoke, which has 17 stores, mostly within the Greater Toronto Area, and nine lease commitments in other favourable communities. But last week, 180 Smoke became a licensed distributor in Canada for JUUL, the world’s leading e-cigarette/vape company and one which has about three per cent of the US$100 billion cigarette market in the United States.

The move could be a big deal for Origin House, Cooper says.

“In Canada, the cigarette market is ~$14 billion (excluding taxes) based on 27 billion cigarettes sold in 2017. A 3 per cent share of the vape market would represent a current $500 million market with a strong growth rate. If JUUL were to have a 75 per cent share in Canada, that would be a $375 million revenue market in Canada,” writes Cooper in a client update on Wednesday.

Cooper says the market has yet to fully account for 180 Smoke’s value for OH, saying that if the projected outcome vis a vis JUUL comes to fruition, then OH would be acquiring 180 Smoke “at a very good price.”

“At the current price, we do not believe much attention nor value accretion has been assigned to 180 Smoke. This could change dramatically with the addition of JUUL,” he says.

Cooper sees OH generating 2019 EBITDA of $13.5 million on revenue of $198.8 million and 2020 EBITDA of $50.2 million on a top line of $425.0 million. He is reiterating his “Buy” rating and $13.00 target price for OH, which represents a projected 12-month return of 38 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: oh
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

4 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

7 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

8 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

8 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 days ago